Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Clinical Pharmacology and Biopharmacy|March 1, 1977
Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration manW H Aellig, E NüeschEuropean Journal of Clinical Pharmacology|January 1, 1986
Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administrationW H Aellig, J RosenthalerBritish Journal of Clinical Pharmacology|January 1, 1987
Is the ISA of pindolol beta 2-adrenoceptor selective?W H Aellig, B J ClarkEuropean Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tabletsW H Aellig, E Nüesch, W PachaBritish Journal of Clinical Pharmacology|October 1, 1985
Contrasts between pindolol and propranolol concentration-response relationshipsS G Carruthers, W L Pacha, W H AelligEuropean Journal of Clinical Pharmacology|January 1, 1991
Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjectsP A Wyss, J Rosenthaler, E Nüesch, et al.British Journal of Clinical Pharmacology|January 1, 1986
Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindololW H Aellig, E Nüesch, G Engel, et al.European Journal of Clinical Pharmacology|January 1, 1981
A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tabletW H Aellig, H H Narjes, E Nüesch, et al.British Journal of Clinical Pharmacology|January 1, 1982
The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemiaK J Schlüter, W H Aellig, K G Petersen, et al.Pageof 3